ZA974546B - Medicinal aerosol formulations of formoterol - Google Patents

Medicinal aerosol formulations of formoterol

Info

Publication number
ZA974546B
ZA974546B ZA974546A ZA974546A ZA974546B ZA 974546 B ZA974546 B ZA 974546B ZA 974546 A ZA974546 A ZA 974546A ZA 974546 A ZA974546 A ZA 974546A ZA 974546 B ZA974546 B ZA 974546B
Authority
ZA
South Africa
Prior art keywords
formoterol
aerosol formulations
medicinal aerosol
medicinal
formulations
Prior art date
Application number
ZA974546A
Other languages
English (en)
Inventor
Martin James Oliver
Simon Gordon Paling
Philip Anthony Jinks
Sukhbinder Kaur Jaiswal
Original Assignee
Minnesota Mining & Mfg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10795182&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA974546(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Minnesota Mining & Mfg filed Critical Minnesota Mining & Mfg
Publication of ZA974546B publication Critical patent/ZA974546B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/124—Aerosols; Foams characterised by the propellant

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
ZA974546A 1996-06-11 1997-05-23 Medicinal aerosol formulations of formoterol ZA974546B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9612297.3A GB9612297D0 (en) 1996-06-11 1996-06-11 Medicinal aerosol formulations

Publications (1)

Publication Number Publication Date
ZA974546B true ZA974546B (en) 1998-11-23

Family

ID=10795182

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA974546A ZA974546B (en) 1996-06-11 1997-05-23 Medicinal aerosol formulations of formoterol

Country Status (16)

Country Link
EP (2) EP1400239A1 (xx)
JP (1) JP5000793B2 (xx)
AR (1) AR009231A1 (xx)
AT (1) ATE275940T1 (xx)
AU (1) AU726382B2 (xx)
CA (1) CA2257841C (xx)
DE (1) DE69730723T2 (xx)
DK (1) DK0934057T3 (xx)
ES (1) ES2229366T3 (xx)
GB (1) GB9612297D0 (xx)
ID (1) ID19520A (xx)
NO (1) NO320403B1 (xx)
NZ (1) NZ333202A (xx)
PT (1) PT934057E (xx)
WO (1) WO1997047286A1 (xx)
ZA (1) ZA974546B (xx)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6054488A (en) * 1996-06-11 2000-04-25 3M Innovative Properties Company Medicinal aerosol formulations of formoterol
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
US6423298B2 (en) * 1998-06-18 2002-07-23 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceutical formulations for aerosols with two or more active substances
US6451285B2 (en) * 1998-06-19 2002-09-17 Baker Norton Pharmaceuticals, Inc. Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant
DE19847969A1 (de) * 1998-10-17 2000-04-20 Boehringer Ingelheim Pharma Lagerfähig flüssige Formulierung mit Formoterol
CN1187044C (zh) * 1998-10-17 2005-02-02 贝林格尔英格海姆法码两合公司 可储存的含福莫特罗的活性物质浓缩液
DZ2947A1 (fr) 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
IT1303788B1 (it) 1998-11-25 2001-02-23 Chiesi Farma Spa Formulazioni di aerosol medicinali.
US6290930B1 (en) 1998-12-18 2001-09-18 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes and budesonide
US6004537A (en) * 1998-12-18 1999-12-21 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol
IT1313553B1 (it) 1999-07-23 2002-09-09 Chiesi Farma Spa Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
IT1317846B1 (it) 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
CN1213732C (zh) * 2000-05-22 2005-08-10 奇斯药制品公司 用于加压计量吸入器的稳定药用溶液制剂
SE0004750D0 (sv) 2000-12-19 2000-12-19 Astrazeneca Ab Novel formulation
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
ATE267591T1 (de) 2001-07-02 2004-06-15 Chiesi Farma Spa Optimierte tobramycin-formulierung zur aerosolbildung
TWI324934B (en) * 2001-08-28 2010-05-21 Schering Corp Pharmaceutical compositions for the treatment of asthma
GB0207906D0 (en) 2002-04-05 2002-05-15 3M Innovative Properties Co Formoterol and mometasone aerosol formulations
GB0207899D0 (en) * 2002-04-05 2002-05-15 3M Innovative Properties Co Formoterol and cielesonide aerosol formulations
DE60336602D1 (de) * 2002-08-27 2011-05-12 Schering Corp Verfahren zur Herstellung von Formulierungen für Inhaliergeräte mit abgemessener Dosis
WO2004110460A1 (en) * 2003-06-13 2004-12-23 Altana Pharma Ag Formoterol and ciclesonide combination
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
JP2007509147A (ja) * 2003-10-20 2007-04-12 シェーリング　コーポレイション 薬学的エアロゾル組成物
EP1925293A3 (en) * 2003-10-20 2010-01-13 Schering Corporation Pharmaceutical aerosol compositions
EP1595531A1 (en) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers
MX2009004198A (es) * 2006-10-17 2009-10-19 Lithera Inc Metodos, composiciones y formulaciones para el tratamiento de enfermedad ocular tiroidea.
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
PL3106149T3 (pl) 2009-05-29 2020-06-01 Pearl Therapeutics, Inc. Kompozycje do płucnego dostarczania długo-działających antagonistów muskarynowych i długo-działających agonistów receptora beta-2 adrenergicznego oraz powiązane sposoby i układy
PT2482799E (pt) * 2009-10-02 2014-08-06 Chiesi Farma Spa Formulações farmacêuticas de aerossol de formoterol e de dipropionato de beclometasona
ES2712988T5 (es) 2013-03-15 2022-10-21 Pearl Therapeutics Inc Métodos y sistemas para acondicionamiento de materiales cristalinos en partículas

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05508616A (ja) * 1989-02-23 1993-12-02 ローヌー　プーラン　ローラー　インターナショナル（ホウルディングス）インコーポレイテッド 治療用エアロゾル剤
IL97065A (en) * 1990-02-02 1994-01-25 Fisons Plc Repellent preparations for aerosol
GB9024365D0 (en) * 1990-11-09 1991-01-02 Glaxo Group Ltd Medicaments
EP0504112A3 (en) * 1991-03-14 1993-04-21 Ciba-Geigy Ag Pharmaceutical aerosol formulations
ATE339952T1 (de) * 1991-06-10 2006-10-15 Schering Corp Fluorchlorkohlenwasserstofffreie aerosolformulierungen
DE69231994T3 (de) * 1991-06-10 2010-01-21 Schering Corp. Fluorchlorkohlenwasserstofffreie Aerosolformulierungen
IL104068A (en) * 1991-12-12 1998-10-30 Glaxo Group Ltd Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant
NZ246046A (en) * 1991-12-12 1995-12-21 Glaxo Group Ltd Aerosol comprising a particulate medicament in a fluorocarbon or chlorofluorohydrocarbon and a polar cosolvent
DE69218455T2 (de) * 1991-12-18 1997-10-23 Minnesota Mining And Mfg. Co., Saint Paul, Minn. Aerosolzusammensetzungen für arzneimittelsuspensionen
GB9207400D0 (en) * 1992-04-02 1992-05-13 Smithkline Beecham Plc Novel use
US5354934A (en) * 1993-02-04 1994-10-11 Amgen Inc. Pulmonary administration of erythropoietin
GB9425160D0 (en) * 1994-12-10 1995-02-08 Glaxo Group Ltd Medicaments
GB9426252D0 (en) * 1994-12-24 1995-02-22 Glaxo Group Ltd Pharmaceutical composition

Also Published As

Publication number Publication date
AR009231A1 (es) 2000-04-12
NO985720D0 (no) 1998-12-07
CA2257841A1 (en) 1997-12-18
DK0934057T3 (da) 2005-01-24
JP5000793B2 (ja) 2012-08-15
NO985720L (no) 1999-02-11
DE69730723T2 (de) 2005-10-06
EP1400239A1 (en) 2004-03-24
CA2257841C (en) 2008-05-20
EP0934057A1 (en) 1999-08-11
AU726382B2 (en) 2000-11-02
ATE275940T1 (de) 2004-10-15
GB9612297D0 (en) 1996-08-14
JP2000513340A (ja) 2000-10-10
AU3373997A (en) 1998-01-07
PT934057E (pt) 2004-12-31
EP0934057B1 (en) 2004-09-15
ID19520A (id) 1998-07-16
NO320403B1 (no) 2005-11-28
DE69730723D1 (de) 2004-10-21
WO1997047286A1 (en) 1997-12-18
ES2229366T3 (es) 2005-04-16
NZ333202A (en) 2000-06-23

Similar Documents

Publication Publication Date Title
ZA974546B (en) Medicinal aerosol formulations of formoterol
IL116460A0 (en) Aerosol drug formulations
ZA975883B (en) High dose liposomal aerosol formulations
HUP0000795A3 (en) Medicinal aerosol formulations comprising budesonide
AP9500733A0 (en) Pharmaceutical formulations
HUT77377A (hu) Aeroszol készítmények
ZA951781B (en) Pharmaceutical formulations
PL348975A1 (en) Pharmaceutical aerosol formulations containing fluoroalkanes and budesonide
EG21177A (en) Insecticidal aerosol composition and insecticidal composition for preparation of same
IL128714A0 (en) Chlorofluorocarbon-free mometasone furoate aerosol formulations
AU1847695A (en) Pharmaceutical formulations of cntf
IL112897A0 (en) Aerosol drug formulations containing vitamin e
GB9304745D0 (en) Use of pharmaceutical formulations
GB9413542D0 (en) Pharmaceutical formulations
ZA9510754B (en) Aerosol drug formulations
ZA976038B (en) Medicinal aerosol solution formulation
ZA956970B (en) Improved pharmaceutical formulations their preparation and use
GB9408161D0 (en) Pharmaceutical formulations
GB9414216D0 (en) Pharmaceutical formulations
GB9417953D0 (en) Pharmaceutical formulations
GB9426113D0 (en) Pharmaceutical formulations
GB9408163D0 (en) Pharmaceutical formulations
ZA953239B (en) Pharmaceutical formulations
GB9408151D0 (en) Pharmaceutical formulations
GB9401738D0 (en) Pharmaceutical formulations